News/ News/ Oncology Trial flop busts Deciphera’s blockbuster hopes for Qinlock Phil Taylor Deciphera, GIST, novel targeted cancer treatments, Oncology, Qinlock 0 Comment Shares in Deciphera Pharma went into freefall on Friday after top-line results of a phase 3 trial of Share X Trial flop busts Deciphera’s blockbuster hopes for Qinlock https://pharmaphorum.com/news/trial-flop-busts-decipheras-blockbuster-hopes-for-qinlock/
News/ News/ Oncology European regulators back Blueprint’s Ayvakyt for stomach tumours Richard Staines Blueprint Medicines, cancer, GIST, stomach cancer 0 Comment European regulators have recommended a licence for Blueprint Medicines’ Ayvakyt (avapritinib), for adults with stomach tumours with certain Share X European regulators back Blueprint’s Ayvakyt for stomach tumours https://pharmaphorum.com/news/european-regulators-back-blueprints-ayvakyt-for-stomach-tumours/
Deciphera, GIST, novel targeted cancer treatments, Oncology, Qinlock
0 Comment
